These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 10713305)
1. Aromatase inhibitors and their application in breast cancer treatment*. Brodie AM; Njar VC Steroids; 2000 Apr; 65(4):171-9. PubMed ID: 10713305 [TBL] [Abstract][Full Text] [Related]
2. Use of aromatase inhibitors in breast carcinoma. Santen RJ; Harvey HA Endocr Relat Cancer; 1999 Mar; 6(1):75-92. PubMed ID: 10732791 [TBL] [Abstract][Full Text] [Related]
3. Biology of aromatase inhibitors: pharmacology/endocrinology within the breast. Miller WR Endocr Relat Cancer; 1999 Jun; 6(2):187-95. PubMed ID: 10731108 [TBL] [Abstract][Full Text] [Related]
4. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model. Long BJ; Jelovac D; Thiantanawat A; Brodie AM Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443 [TBL] [Abstract][Full Text] [Related]
5. Aromatase, its inhibitors and their use in breast cancer treatment. Brodie AM Pharmacol Ther; 1993 Dec; 60(3):501-15. PubMed ID: 8073072 [TBL] [Abstract][Full Text] [Related]
6. Aromatase inhibitors for breast cancer in postmenopausal women. Campos SM Oncologist; 2004; 9(2):126-36. PubMed ID: 15047917 [TBL] [Abstract][Full Text] [Related]
7. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer. Cohen MH; Johnson JR; Li N; Chen G; Pazdur R Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893 [TBL] [Abstract][Full Text] [Related]
8. Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer. Dunn C; Keam SJ Pharmacoeconomics; 2006; 24(5):495-517. PubMed ID: 16706574 [TBL] [Abstract][Full Text] [Related]
9. An overview of the use of non-steroidal aromatase inhibitors in the treatment of breast cancer. Buzdar A Eur J Cancer; 2000 Sep; 36 Suppl 4():S82-4. PubMed ID: 11056331 [TBL] [Abstract][Full Text] [Related]
10. Aromatase and its inhibitors in breast cancer treatment--overview and perspective. Brodie AM; Santen RJ Breast Cancer Res Treat; 1994; 30(1):1-6. PubMed ID: 7949200 [TBL] [Abstract][Full Text] [Related]
11. Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable? Carlini P; Frassoldati A; De Marco S; Casali A; Ruggeri EM; Nardi M; Papaldo P; Fabi A; Paoloni F; Cognetti F Ann Oncol; 2001 Nov; 12(11):1539-43. PubMed ID: 11822752 [TBL] [Abstract][Full Text] [Related]
12. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer. Roseman BJ; Buzdar AU; Singletary SE J Surg Oncol; 1997 Nov; 66(3):215-20. PubMed ID: 9369969 [TBL] [Abstract][Full Text] [Related]
13. New aromatase inhibitors in the treatment of advanced breast cancer. Crucitta E; Lorusso V; Attolico M; Sambiasi D; Mazzei A; De Lena M Int J Oncol; 2000 Nov; 17(5):1037-41. PubMed ID: 11029510 [TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibitors and their use in the sequential setting. Coombes RC; Harper-Wynne C; Dowsett M Endocr Relat Cancer; 1999 Jun; 6(2):259-63. PubMed ID: 10731118 [TBL] [Abstract][Full Text] [Related]
17. The evolving role of aromatase inhibitors in breast cancer. Mokbel K Int J Clin Oncol; 2002 Oct; 7(5):279-83. PubMed ID: 12402060 [TBL] [Abstract][Full Text] [Related]